Skip to main content

Peripheral Artery Thrombosis clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • JETi Peripheral Thrombectomy Registry

    open to eligible people ages 18 years and up

    The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi® Peripheral Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers in the US and Europe. Subjects participating in this registry will be followed through their 12-month follow up visit.

    at UCLA

Last updated: